OClawVPS.com
IQVIA
Edit

IQVIA

https://www.iqvia.com/
Last activity: 31.03.2026
Active
Categories: AssistedDataHealthTechHumanLifeMedTechProviderScienceServiceTechnology
IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 70,000 employees, IQVIA conducts operations in more than 100 countries. To learn more, visit www.iqvia.com.
Likes
52.98K
Followers
1.11M
Website visits
846.8K /mo.
Mentions
255
Location: United States, North Carolina, Durham
Employees: 10001+
Phone: +1 919-998-2000
Founded date: 2016

Investors 1

Mentions in press and media 255

DateTitleDescription
31.03.2026Stephen Corba Addresses Clinical Research, Comparator Sourcing, and Drug Cost ReductionStephen Corba MONMOUTH COUNTY, NJ, UNITED STATES, March 30, 2026 /EINPresswire.com/ -- Stephen Corba, a healthcare logistics and clinical research infrastructure professional with more than 20 years of experience, today issued a statement a...
20.03.2026QHP Capital: $1.1 Billion Continuation Vehicle Raised For Azurity PharmaceuticalsQHP Capital has closed a $1.1 billion single-asset continuation vehicle to support its portfolio company Azurity Pharmaceuticals, providing liquidity to existing investors while positioning the business for continued long-term growth. The t...
16.03.2026Nvidia launches enterprise AI agent platform with Adobe, Salesforce, SAP among 17 adopters at GTC 2026Jensen Huang walked onto the GTC stage Monday wearing his trademark leather jacket and carrying, as it turned out, the blueprints for a new kind of monopoly. The Nvidia CEO unveiled the Agent Toolkit, an open-source platform for building au...
07.03.2026Should drug companies be advertising to consumers?Getting your Trinity Audio player ready... By Paula Span, KFF Health News Tamar Abrams had a lousy couple of years in 2022 and ’23. Both her parents died; a relationship ended; she retired from communications consulting. She moved from Arli...
17.02.2026Moberg Pharma Year-end report 2025Moberg Pharma Year-end report 2025 Tue, Feb 17, 2026 08:00 CET Report this content A BREAKTHROUGH YEAR WITH A CLEAR PATH TO EUROPE THE YEAR (JAN-DEC 2025) Net revenue SEK 13.5 million (9.8) EBITDA SEK -25.7 million (-23.5) Operating profit ...
10.02.2026Basketball Superstar Kevin Durant Becomes the "New Face of Legs" in CeraVe's Latest "Moisturise Like a Derm" CampaignThe Social-First Edutainment Campaign Champions Total Body Skin Health, Emphasising CeraVe's Solutions to Common Skin Issues NEW YORK, Feb. 10, 2026 /PRNewswire/ -- CeraVe, the #1 recommended moisturiser brand by dermatologists worldwide, t...
05.02.2026IQVIA backs AI strategy as analysts question impact on businessFeb 5 : Healthcare data and clinical research provider IQVIA Holdings on Thursday defended its AI strategy against analyst concerns that recent technology advances could displace the company's services, after it forecast annual profit below...
29.01.2026uMotif Posts Strong Growth, Earns Market Accolades for eCOA Platform, Demonstrates Continued Clinical Trial Industry Leadership in 2025Everest Group gives uMotif highest possible technology rating in eCOA market assessment; Chief Scientific Officer Florence Mowlem PhD leads C-Path publication of industry-wide Event-Driven eDiary best practices in Nature Digital Medicine; f...
27.01.2026Servier delivers solid performance in 2024/25 and confirms its forecasts for 2030Servier reported Group revenues of €6.9 billion for 2024/25, up 16.2% from 2023/24. Growth over the financial year was driven by increased sales in oncology, particularly in the United States. Several partnership agreements in oncology and ...
16.01.2026Novo Nordisk shares rise 8% after Wegovy obesity pill has ‘solid’ launchShares of Novo Nordisk rose more than 8% on Friday after early prescription data showed an encouraging start to the launch of the company’s new GLP-1 pill for obesity in the U.S. In a Friday note, TD Cowen analysts called it a “solid start”...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In